AMANDA FIELD: Open Payments
NPI 1134893480 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$244 in 10 payments from 8 companies in 2025. Trend: 2023 $62 · 2024 $137 · 2025 $244
Food & beverage: $244
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $61 |
| Grifols USA, LLC | 1 | $35 |
| Actelion Pharmaceuticals US, Inc. | 1 | $29 |
| United Therapeutics Corporation | 1 | $28 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| Viatris Specialty LLC | 1 | $24 |
| Astellas Pharma US Inc | 1 | $21 |
| Genentech USA, Inc. | 1 | $20 |
Products named: LIVTENCITY, Prolastin-C Liquid, OPSUMIT, WINREVAIR, YUPELRI, Cresemba, Xolair, GLASSIA.
Industry payments across AZ — which companies pay providers there.
